Oligometastatic prostate cancer (omPCa) represents an intermediate stage of cancer dissemination between localized and widely metastatic disease. With dramatic improvements in staging—particularly through advanced functional imaging such as PSMA-PET and robotic-assisted (RA) targeted biopsies (RA-TB)—omPCa is now more frequently detected, both at primary diagnosis and in oligorecurrent disease (Patel et al., 2020). Singh et al.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile